Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit

Abstract Background Alzheimer’s disease (AD) is a complex and heterogeneous disease, which requires reliable biomarkers for diagnosis and monitoring disease activity. Preanalytical protocol and technical variability associated with biomarker immunoassays makes comparability of biomarker data across...

Full description

Bibliographic Details
Main Authors: Sterling C. Johnson, Marc Suárez-Calvet, Ivonne Suridjan, Carolina Minguillón, Juan Domingo Gispert, Erin Jonaitis, Agata Michna, Margherita Carboni, Tobias Bittner, Christina Rabe, Gwendlyn Kollmorgen, Henrik Zetterberg, Kaj Blennow
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Amyloid-β
Cerebrospinal fluid biomarkers
Glial activation
Inflammation
Neurodegeneration
Online Access:https://doi.org/10.1186/s13195-023-01168-y

Internet

https://doi.org/10.1186/s13195-023-01168-y

Similar Items